A concentration-dependent effect of ursodeoxycholate on apoptosis and caspases activities of HepG2 hepatocellular carcinoma cells

European Journal of Pharmacology

Volumn 640, Issue 1-3, 2010, Pages 1-7

  Tsagarakis, Nikos J ^a   Drygiannakis, Ioannis ^a   Batistakis, Antonis G ^a   Kolios, George ^b   Kouroumalis, Elias A ^a,c  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Apoptosis; Caspase; Hepatocellular carcinoma; HepG2; UDCA; Ursodeoxycholate

Indexed keywords

CASPASE; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; TUMOR NECROSIS FACTOR ALPHA; URSODEOXYCHOLIC ACID; LIGAND; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; DNA FRAGMENTATION; DRUG EFFECT; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAINING; ANTIBODY SPECIFICITY; DOSE RESPONSE; DRUG EFFECTS; HEPG2 CELL LINE; METABOLISM; PATHOLOGY;

ANNEXIN A5; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL PROLIFERATION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; LIGANDS; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; URSODEOXYCHOLIC ACID;

EID: 77953806686     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.023     Document Type: Article

References (29)

1. Attili A.F., Angelico M., Cantafora A., Alvaro D., Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med. Hypotheses 1986, 19:57-69.
2. Cheng Y., Tauschel H.D., Nilsson A., Duan R.D. Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. Scand. J. Gastroenterol. 1999, 34:915-920.
3. Compton S.J., Jones C.G. Mechanism of dye response and interference in the Bradford protein assay. Anal. Biochem. 1985, 151:369-374.
4. Fang Y., Wang L., Jin J., Zha X. Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to tumor necrosis factor-alpha/cycloheximide-induced apoptosis by regulating protein kinase B levels. Eur J Biochem. 2001, 268:4513-4519.
5. Guicciardi M.E., Gores G.J. Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. Hepatology 2002, 35:971-973.
6. Guldutuna S., Zimmer G., Imhof M., Bhatti S., You T., Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 1993, 104:1736-1744.
7. Heuman D.M., Bajaj R.S., Lin Q. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J. Lipid Res. 1996, 37:562-573.
8. Hofmann A.F., Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987, 2:398-399.
9. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N.Engl.J Med 2005, 353:1261-1273.
10. Kerr J.F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 1971, 105:13-20.
11. Lee Y.M., Kaplan M.M. The natural history of PBC: has it changed?. Semin. Liver Dis. 2005, 25:321-326.
12. Leist M., Gantner F., Bohlinger I., Germann P.G., Tiegs G., Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol. 1994, 153:1778-1788.
13. Liu H., Qin C.Y., Han G.Q., Xu H.W., Meng M., Yang Z. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. World J. Gastroenterol. 2007, 13:1652-1658.
14. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. 1997, 22:299-306.
15. Notas G., Kolios G., Mastrodimou N., Kampa M., Vasilaki A., Xidakis C., Castanas E., Thermos K., Kouroumalis E. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors. J Hepatol. 2004, 40:792-798.
16. Orrenius S., McConkey D.J., Bellomo G., Nicotera P. Role of Ca2+ in toxic cell killing. TIPS 1989, 10:281-285.
17. Oyama K., Shiota G., Ito H., Murawaki Y., Kawasaki H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 2002, 23:885-892.
18. Park Y.H., Kim J.A., Baek J.H., Jung E.J., Kim T.H., Suh H., Park M.H., Kim K.W. Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA). Arch.Pharm.Res 1997, 20:29-33.
19. Paumgartner G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525-531.
20. Qiao L., Yacoub A., Studer E., Gupta S., Pei X.Y., Grant S., Hylemon P.B., Dent P. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology 2002, 35:779-789.
21. Que F.G., Phan V.A., Phan V.H., Larusso N.F., Gores G.J. GUDC inhibits cytochrome c release from human cholangiocyte mitochondria. J. Surg. Res. 1999, 83:100-105.
22. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Scudiero D.A., Monks A., Boyd M.R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 1990, 82:1113-1118.
23. Samali A., Nordgren H., Zhivotovsky B., Peterson E., Orrenius S. A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis. Biochem. Biophys. Res. Commun. 1999, 255:6-11.
24. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
25. Tarao K., Fujiyama S., Ohkawa S., Miyakawa K., Tamai S., Hirokawa S., Masaki T., Tanaka K. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. Cancer Epidemiol. Biomarkers Prev. 2005, 14:164-169.
26. Thomas M.B., Zhu A.X. Hepatocellular carcinoma: the need for progress. J. Clin. Oncol. 2005, 23:2892-2899.
27. Troy C.M., Shelanski M.L. Caspase-2 redux. Cell Death Differ. 2003, 10:101-107.
28. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc.Natl.Acad.Sci.U.S.A 1996, 93:2239-2244.
29. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.